SJS Investment Consulting’s Intellia Therapeutics NTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $235 | Hold |
25
| – | – | ﹤0.01% | 1328 |
|
|
2025
Q1 | $178 | Hold |
25
| – | – | ﹤0.01% | 1465 |
|
|
2024
Q4 | $292 | Sell |
25
-1
| -4% | -$12 | ﹤0.01% | 1399 |
|
|
2024
Q3 | $535 | Sell |
26
-2
| -7% | -$41 | ﹤0.01% | 1301 |
|
|
2024
Q2 | $628 | Hold |
28
| – | – | ﹤0.01% | 1215 |
|
|
2024
Q1 | $771 | Hold |
28
| – | – | ﹤0.01% | 1131 |
|
|
2023
Q4 | $855 | Buy |
28
+1
| +4% | +$31 | ﹤0.01% | 1014 |
|
|
2023
Q3 | $855 | Buy |
27
+2
| +8% | +$63 | ﹤0.01% | 1006 |
|
|
2023
Q2 | $1.02K | Hold |
25
| – | – | ﹤0.01% | 897 |
|
|
2023
Q1 | $932 | Hold |
25
| – | – | ﹤0.01% | 920 |
|
|
2022
Q4 | $872 | Hold |
25
| – | – | ﹤0.01% | 1004 |
|
|
2022
Q3 | $1K | Buy |
+25
| New | +$1K | ﹤0.01% | 839 |
|
|
2022
Q1 | $16K | Hold |
225
| – | – | ﹤0.01% | 329 |
|
|
2021
Q4 | $27K | Buy |
+225
| New | +$27K | 0.01% | 231 |
|